SASOF Financials 07/16/2014 03:34:17 Sasol Ltd. Period

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
SASOF Financials 07/16/2014 03:34:17
Sasol Ltd.
Period Ending Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 20,718,000 21,011,000 15,948,000
Cost of Revenue 13,577,000 13,345,000 10,329,000
Gross Profit 7,141,000 7,666,000 5,619,000
Operating Expenses
Research and Development - - -
Sales, General and Admin. 2,676,000 3,099,000 2,365,000
Non-Recurring Items - - -
Other - - -
Operating Income 4,494,000 4,418,000 3,123,000
Income From Continuing Operations
Add'l Income/Expense Items 127,000 (4,000) 43,000
Earnings Before Interest and Tax 4,650,000 4,607,000 3,325,000
Interest Expense 248,000 268,000 276,000
Earnings Before Tax 4,402,000 4,339,000 3,049,000
Income Tax 1,436,000 1,357,000 911,000
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary 59,000 43,000 28,000
Net Income Cont. Operations 3,025,000 3,026,000 2,166,000
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 2,966,000 2,983,000 2,138,000
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 2,966,000 2,983,000 2,138,000

Sasol Ltd. (SASOF) Stock Research Links

SASOF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Unlocking Revolutionary Golf Insights with XView AI for All Levels

Updated Category News Views 1046

Revolutionizing Golf Swing Analysis with XView AI In an exciting advancement for golfers everywhere, IdeasLab has unveiled XView AI, an innovative markerless app designed to deliver comprehensive golf swing analysis in real time. This app, endorsed by renowned PGA Tour Champion K.J. Choi and celebrated coach Pete Buchanan, presents an accessible solution for coaches,...

Continue Reading
Ultragenyx Pharmaceutical Under Scrutiny: Investor Investigation Ongoing

Updated Category News Views 255

Investigation into Ultragenyx Pharmaceutical Inc. Pomerantz LLP has initiated an inquiry into potential claims for investors of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE). The firm is reaching out to investors for feedback and insights amidst concerns of possible unlawful practices involving the company's management. Concerns of Unlawful Business Practices The...

Continue Reading
Arras Minerals Set to Shine at Upcoming Minerals Investor Event

Updated Category News Views 135

Arras Minerals Invites Investors to Join Virtual Conference Arras Minerals Corp (TSXV: ARK, OTCQB: ARRKF) from Vancouver, Canada, has made a significant announcement about its upcoming participation in a virtual conference focusing on precious and critical minerals. This event is particularly important for those interested in exploring investment opportunities in...

Continue Reading
Unlocking New Income Streams with PBK Miner’s Cloud Mining

Updated Category News Views 302

Revolutionizing Mining: The Future of XRP Income The innovative approach to XRP mining through cloud contracts is starting to resonate with investors, particularly as XRP faces resistance around the $2.4 mark. Recent developments have shown that while XRP has struggled, innovative platforms like PBK Miner provide opportunities for passive income generation for crypto...

Continue Reading
Modine's Strategic Acquisition of L.B. White: Market Expansion

Updated Category News Views 318

Modine's Acquisition of L.B. White to Enhance Heating Technology Modine, a global leader in thermal management technologies, recently made headlines by announcing its acquisition of L.B. White, a prominent provider of specialized heating solutions. This strategic move not only diversifies Modine’s portfolio but also strengthens its position in the HVAC industry. By...

Continue Reading